Incyte

Ultime notizie

Titoli nella lingua originale della fonte.

• Wells Fargo Adjusts Price Target on Incyte to $128 From $116, Keeps Equalweight Rating (si apre in una nuova scheda)

  marketscreener.com · 1 ott 2026

• Incyte presents EADV data for Incyte stock (si apre in una nuova scheda)

  AD HOC NEWS · 1 ott 2026

• Incyte stock trades at EUR 110.18 after an Atebrioz target hike (si apre in una nuova scheda)

  AD HOC NEWS · 29 set 2026

• Incyte stock at USD 124.31 on September 28, 2026 (si apre in una nuova scheda)

  AD HOC NEWS · 28 set 2026

• Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment (si apre in una nuova scheda)

  Benzinga · 28 set 2026

• Mirum and Incyte gain approval of zilurgisertib for rare bone disorder (si apre in una nuova scheda)

  Seeking Alpha · 26 set 2026

• Incyte Stock Price Forecast. Should You Buy INCY? (si apre in una nuova scheda)

  StockInvest.us · 25 set 2026

• Incyte stock reports 38 percent revenue growth as shares trade at USD 123.47 (si apre in una nuova scheda)

  AD HOC NEWS · 25 set 2026

• Form 4 Incyte Corporation For: 25 September By Investing.com (si apre in una nuova scheda)

  Investing.com UK · 25 set 2026

• Incyte stock heads into the open after a 1.23 percent drop (si apre in una nuova scheda)

  AD HOC NEWS · 25 set 2026

• Incyte stock holds near its yearly high as RBC keeps target (si apre in una nuova scheda)

  AD HOC NEWS · 23 set 2026

• Incyte Expands Skin Diseases Treatment Partnership in Australia (si apre in una nuova scheda)

  marketscreener.com · 21 set 2026

• Incyte stock gains attention as Opzelura partnership in Australia expands (si apre in una nuova scheda)

  AD HOC NEWS · 21 set 2026

• What Is Incyte Corporation (NASDAQ:INCY) Signaling Through Its Pipeline? (si apre in una nuova scheda)

  Kalkine Media · 18 set 2026

• Incyte stock gains after Morgan Stanley conference highlights pipeline strategy (si apre in una nuova scheda)

  AD HOC NEWS · 17 set 2026

• Incyte stock heads into the open after a 0.4% slip (si apre in una nuova scheda)

  AD HOC NEWS · 17 set 2026

• Incyte: Priced For Success, With No Margin Of Safety (NASDAQ:INCY) (si apre in una nuova scheda)

  Seeking Alpha · 15 set 2026

• Incyte (INCY): 3 Reasons We Love This Stock (si apre in una nuova scheda)

  Yahoo Finance · 14 set 2026

• Incyte stock gains institutional support as shares trade near 52-week high (si apre in una nuova scheda)

  AD HOC NEWS · 11 set 2026

• Incyte: Solid Strategies For Continued Growth, But A Possible Pullback Looms (NASDAQ:INCY) (si apre in una nuova scheda)

  Seeking Alpha · 8 set 2026